Short Interest in Siemens Healthineers AG (OTCMKTS:SMMNY) Rises By 143.6%

Siemens Healthineers AG (OTCMKTS:SMMNY) saw a significant increase in short interest in the month of July. As of July 15th, there was short interest totaling 125,563 shares, an increase of 143.6% from the June 30th total of 51,538 shares. Based on an average daily volume of 209,024 shares, the short-interest ratio is presently 0.6 days.

Analysts Set New Price Targets

Separately, Zacks Research cut shares of Siemens Healthineers from a “hold” rating to a “strong sell” rating in a research report on Friday, May 15th. One equities research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy”.

Siemens Healthineers Trading Up 2.0%

Siemens Healthineers stock opened at $20.19 on Tuesday. The company has a 50 day moving average of $19.86 and a 200-day moving average of $21.94. Siemens Healthineers has a twelve month low of $19.20 and a twelve month high of $28.92.

Siemens Healthineers (OTCMKTS:SMMNY) last posted its quarterly earnings data on Thursday, May 7th. The company reported $0.31 EPS for the quarter, beating the consensus estimate of $0.29 by $0.02. The company had revenue of $6.68 billion during the quarter, compared to the consensus estimate of $6.96 billion.

About Siemens Healthineers

Siemens Healthineers AG is a leading global medical technology company that develops, manufactures and distributes a broad range of products and services for the healthcare sector. Headquartered in Erlangen, Germany, the company focuses on diagnostic and therapeutic imaging, in vitro diagnostics and advanced digital health solutions. As a spin-off from Siemens AG, Siemens Healthineers has leveraged decades of engineering expertise to establish a comprehensive portfolio that addresses critical needs in modern healthcare.

The company’s core offerings include magnetic resonance imaging (MRI), computed tomography (CT), X-ray and molecular imaging systems, as well as laboratory diagnostics equipment and point-of-care testing devices.